Trials / Sponsors / Max-Planck-Institute of Experimental Medicine
Max-Planck-Institute of Experimental Medicine
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke Infarction, Middle Cerebral Artery, Middle Cerebral Artery Stroke, Stroke, Acute | Phase 2 / Phase 3 | 2003-01-01 |